Tucows Reports Continuing Strong Financial Results for Third Quarter of 2016
Nov 07, 2016 21:06 pm UTC| Business
TORONTO, Nov. 07, 2016 -- Tucows Inc. (NASDAQ:TCX) (TSX:TC), a provider of network access, domain names and other Internet services, today reported its financial results for the third quarter ended September 30, 2016....
PRA Group Reports Third Quarter 2016 Results
Nov 07, 2016 21:06 pm UTC| Business
NORFOLK, Va., Nov. 07, 2016 -- PRA Group, Inc. (Nasdaq:PRAA), a global leader in acquiring and collecting nonperforming loans, today reported its financial results for the third quarter of 2016. The company reported...
Cray Inc. Reports Third Quarter 2016 Financial Results
Nov 07, 2016 21:06 pm UTC| Business
SEATTLE, Nov. 07, 2016 -- Global supercomputer leader Cray Inc. (Nasdaq:CRAY) today announced financial results for the third quarter ended September30, 2016. All figures in this release are based on U.S. GAAP unless...
Connecture Reports Financial Results for Third Quarter 2016
Nov 07, 2016 21:06 pm UTC| Business
BROOKFIELD, Wis., Nov. 07, 2016 -- Connecture, Inc.(Nasdaq:CNXR), a provider of web-based information systems used to create health insurance marketplaces, today announced financial results for the quarter ended...
Portola Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Nov 07, 2016 21:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2016 -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) today provided a corporate update and reported its financial results for the third quarter ended September 30, 2016. “We...
Ultragenyx Reports Third Quarter 2016 Financial Results and Corporate Update
Nov 07, 2016 21:05 pm UTC| Business
NOVATO, Calif., Nov. 07, 2016 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported its financial...
Kura Oncology Reports Third Quarter 2016 Financial Results
Nov 07, 2016 21:05 pm UTC| Business
LA JOLLA, Calif., Nov. 07, 2016 -- Kura Oncology, Inc., (Nasdaq:KURA) a clinical stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today reported...